Prosvent
Prosvent, licence 80062113: active licence in Health Canada data. The French and European references below do not constitute authorisation for sale in France or an assessment of safety or efficacy.
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
Natural health product licensed in Canada
- Licence holder
- Therabotanics, LLC
- NPN or DIN-HM
- 80062113
- Status
- Active licence
- Licence date
- 23 June 2015
- Revision date
- Not provided
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
- Conditions légales
Serenoa repens (W.Bartram) Small: L'étiquetage doit comporter une mention recommandant de prendre conseil auprès d'un professionnel de santé ("Demander l'avis de votre médecin et /ou pharmacien").
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
- Conditions légales
Urtica dioica L.: L'étiquetage des compléments alimentaires contenant les parties souterraines de cette plante doit comporter une mention recommandant de prendre conseil auprès d'un professionnel de santé ("Demander l'avis de votre médecin et /ou pharmacien").
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
- Conditions légales
Prunus africana (Hook. f.) Kalkman: L'étiquetage doit comporter une mention recommandant de prendre conseil auprès d'un professionnel de santé.
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Stérols végétaux libres Source : Stérols végétaux libres Potency : 88.0 % Combined beta-Sitosterol, Campesterol and Stigmasterol | 155.0 milligramme | Not calculated |
| Serenoa repens Source : Fruit Extract : Matériel brut sec Extraction ratio : 12.0:1.0 Dry plant equivalent : 600.0 milligramme Potency : 95.0 % Fatty acids | 50.0 milligramme | Not calculated |
| Urtica dioica Source : Racine Extract : Matériel brut sec Extraction ratio : 10.0:1.0 Dry plant equivalent : 1800.0 milligramme Potency : 0.8 % beta-Sitosterol | 180.0 milligramme | Not calculated |
| Cucurbita pepo Source : Graine(s) | 5.0 milligramme | Not calculated |
| Prunus africana Source : Écorce (tige) Extract : Matériel brut sec Extraction ratio : 200.0:1.0 Dry plant equivalent : 500.0 milligramme Potency : 2.5 % beta-Sitosterol | 2.5 milligramme | Not calculated |
| Lycopène tout trans Source : Lycopène | 3.25 milligramme | Not calculated |
| Piper nigrum Source : Fruit Potency : 95.0 % Piperine | 0.4 milligramme | Not calculated |
| Zinc Source : Sulfate de zinc | 5.0 milligramme | 10,000 µg |
| Vitamine D Source : Cholécalciférol Potency : 100.0 Unités internationales | 2.5 microgrammes | Not calculated |
Non-medicinal ingredients
Huile de soja, Glycérine, Gélatine, Rouge FD&C N° 40, NA, Eau, Cire d'abeille, Bleu FD&C n° 1, Lécithine, Dioxyde de titane
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes de sexe masculin | Not specified | 1.0 Capsule | 2.0 Tous les jours |
Uses authorised in Canada
Text supplied in English because no French text is available.
Helps to support prostate health. Helps to maintain immune function. Helps in connective tissue formation. Used in Herbal Medicine to help reduce difficulty in urination associated with the early stages of benign prostatic hyperplasia (BPH). The ingredients in Prosvent provide significant relief from the symptoms of an enlarged prostate. Prosvent has beta sitosterol which has been scientifically shown in multiple clinical studies to significantly improve urine flow. Prosvent also contains the antioxidant lycopene to help protect the prostate's health. Saw palmetto is used in Herbal Medicine to help relieve the urologic symptoms (e.g., weak urine flow, incomplete voiding, frequent daytime and nighttime urination) associated with mild to moderate benign prostatic hyperplasia.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Warnings are available in English on the official record.
Source
Official Health Canada record, licence 80062113
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.